Open AccessAzadirachtin-A a bioactive compound from Azadiracta indica is a potential inhibitor of SARS-CoV-2 main protease
Author(s) -
Eustace Bonghan Berinyuy,
Jonathan Ibrahim,
Blessing U. Alozieuwa
Publication year - 2021
Publication title -
aroc in pharmaceutical and biotechnology
Language(s) - English
Resource type - Journals
ISSN - 2789-3928
DOI - 10.53858/arocpb01010108
Subject(s) - protease , docking (animal) , chemistry , covid-19 , in silico , pharmacology , enzyme , active site , protease inhibitor (pharmacology) , biochemistry , virology , virus , biology , medicine , infectious disease (medical specialty) , veterinary medicine , disease , antiretroviral therapy , viral load , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom